AB-101
AB-101-03
Phase 1 small_molecule active
Quick answer
AB-101 for Lupus Nephritis - WHO Class III is a Phase 1 program (small_molecule) at Artiva Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Artiva Biotherapeutics
- Indication
- Lupus Nephritis - WHO Class III
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active